Determining sex differences in aortic valve myofibroblast responses to drug combinations identified using a digital medicine platform
Science Advances · 2025
DOI: 10.1126/sciadv.adu2695 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Brandon J Vogt und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shu Chien-Gene Lay Department of Bioengineering, University of California San Diego, La Jolla, CA 92093, USA. Hauptthemen laut MEDLINE: Myofibroblasts, Aortic Valve, Aortic Valve Stenosis, Sex Characteristics. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Aortic valve stenosis (AVS) is a sexually dimorphic disease where aortic valve leaflets develop fibrosis and calcification, leading to heart failure if untreated. Sex differences in AVS progression depend on valvular interstitial cells (VICs) activating to myofibroblasts that drive aberrant extracellular matrix remodeling. To date, no treatment strategies have leveraged cellular sex differences to determine drug combinations that target VIC myofibroblast activation. Here, we harnessed IDentif.AI, an artificial intelligence (AI)–derived platform, to optimize sex-biased synergistic drug combinations that may prevent and reverse VIC myofibroblast activation on hydrogel biomaterials. The results reveal that sex-specific drug response models can be used to predict sex biases in drug efficacy and combinatorial interactions. This study provides a framework for developing AVS treatments through the integration of high-throughput hydrogel cell culture platforms and AI-driven drug optimization. Designing targeted AVS drug combinations may help accelerate AVS drug development and address health disparities in AVS treatment outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Shu Chien-Gene Lay Department of Bioengineering, University of California San Diego, La Jolla, CA 92093, USA.
- Sanford Consortium for Regenerative Medicine, La Jolla, CA 92037, USA.
- Department of Biomedical Engineering, College of Design and Engineering, National University of Singapore, Singapore 117583, Singapore.
- Institute for Digital Medicine (WisDM), Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117456, Singapore.
- The N.1 Institute for Health (N.1), National University of Singapore, Singapore 117456, Singapore.
- Nikon Imaging Center, Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA.
ORCID-Profile: Brandon J Vogt, Peter Wang, Megan Chavez, Peng Guo, Edward Kai-Hua Chow, Dean Ho, Brian A Aguado
Förderung
- NHLBI NIH HHS
Zitieren
APA
Vogt, B. J., Wang, P., Chavez, M., Guo, P., Chow, E. K., Ho, D., & Aguado, B. A. (2025). Determining sex differences in aortic valve myofibroblast responses to drug combinations identified using a digital medicine platform. Science Advances. https://doi.org/10.1126/sciadv.adu2695
Vancouver
Vogt BJ, Wang P, Chavez M, Guo P, Chow EK, Ho D, et al. Determining sex differences in aortic valve myofibroblast responses to drug combinations identified using a digital medicine platform. Science Advances. 2025. doi:10.1126/sciadv.adu2695
BibTeX
@article{Vogt2025,
author = {Vogt, Brandon J and Wang, Peter and Chavez, Megan and Guo, Peng and Chow, Edward Kai-Hua and Ho, Dean and Aguado, Brian A},
title = {Determining sex differences in aortic valve myofibroblast responses to drug combinations identified using a digital medicine platform},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adu2695}
}
EUVIMED